Xponance’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $476K | Buy |
13,088
+536
| +4% | +$19.5K | ﹤0.01% | 973 |
|
|
2025
Q1 | $455K | Buy |
12,552
+347
| +3% | +$12.6K | ﹤0.01% | 965 |
|
|
2024
Q4 | $513K | Buy |
12,205
+940
| +8% | +$39.5K | ﹤0.01% | 942 |
|
|
2024
Q3 | $626K | Buy |
11,265
+174
| +2% | +$9.67K | 0.01% | 867 |
|
|
2024
Q2 | $456K | Buy |
11,091
+1,279
| +13% | +$52.6K | ﹤0.01% | 933 |
|
|
2024
Q1 | $458K | Sell |
9,812
-350
| -3% | -$16.3K | ﹤0.01% | 969 |
|
|
2023
Q4 | $486K | Buy |
10,162
+648
| +7% | +$31K | 0.01% | 937 |
|
|
2023
Q3 | $339K | Buy |
9,514
+53
| +0.6% | +$1.89K | ﹤0.01% | 1009 |
|
|
2023
Q2 | $436K | Buy |
9,461
+1,824
| +24% | +$84.1K | 0.01% | 946 |
|
|
2023
Q1 | $306K | Sell |
7,637
-78
| -1% | -$3.13K | ﹤0.01% | 1039 |
|
|
2022
Q4 | $357K | Buy |
7,715
+1,354
| +21% | +$62.7K | 0.01% | 997 |
|
|
2022
Q3 | $263K | Sell |
6,361
-85
| -1% | -$3.51K | 0.01% | 1027 |
|
|
2022
Q2 | $385K | Buy |
6,446
+750
| +13% | +$44.8K | 0.01% | 948 |
|
|
2022
Q1 | $414K | Sell |
5,696
-22
| -0.4% | -$1.6K | 0.01% | 956 |
|
|
2021
Q4 | $481K | Buy |
5,718
+97
| +2% | +$8.16K | 0.01% | 915 |
|
|
2021
Q3 | $507K | Sell |
5,621
-173
| -3% | -$15.6K | 0.01% | 884 |
|
|
2021
Q2 | $552K | Buy |
+5,794
| New | +$552K | 0.01% | 880 |
|
|
2021
Q1 | – | Sell |
-1,838
| Closed | -$254K | – | 1055 |
|
|
2020
Q4 | $254K | Buy |
+1,838
| New | +$254K | 0.01% | 995 |
|
|
2020
Q3 | – | Sell |
-2,627
| Closed | -$205K | – | 1047 |
|
|
2020
Q2 | $205K | Buy |
+2,627
| New | +$205K | 0.01% | 963 |
|